GlassScriptPhysician profile
Nicole K Geraghty
NPI 1427223494
$3,954.45
in general payments reported to CMS, 2019-2025
31 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $971 · 2022: $664 · 2023: $588 · 2024: $713 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,303 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,303.04 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $780.08 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Otsuka America Pharmaceutical, INC. | $414.67 | 2023-2025 | Rexulti, Nuedexta |
| Lilly USA, LLC | $344.96 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $297.13 | 2021-2025 | Wegovy |
| Esperion Therapeutics, INC. | $287.69 | 2021-2025 | Nexletol |
| Abbvie INC. | $254.79 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $210.52 | 2021-2025 | Evkeeza |
| Pfizer INC. | $197.31 | 2021-2022 | |
| Glaxosmithkline, LLC. | $148.67 | 2021-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $148.05 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Urovant Sciences INC | $120.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.12 | 2021 | |
| Idorsia Pharmaceuticals US INC | $65.93 | 2023 | Quviviq |
| Ardelyx, INC. | $64.78 | 2023-2025 | Ibsrela |
| Abbott Laboratories | $61.30 | 2021-2023 | Freestyle Libre 2 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $61.30 | 2023-2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $61.19 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $41.48 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.29 | 2022-2023 | |
| Axsome Therapeutics, INC. | $34.01 | 2025 | Auvelity |
| Currax Pharmaceuticals LLC | $31.76 | 2023 | Contrave, Nexlizet, Nexletol |
| Eisai INC. | $30.84 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $30.71 | 2021 | |
| Cmp Pharma, INC. | $28.73 | 2022 | |
| Xeris Pharmaceuticals, INC. | $23.82 | 2021 | |
| Avanir Pharmaceuticals, INC. | $21.29 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.92 | 2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $17.91 | 2021 | |
| Lundbeck LLC | $16.89 | 2022 | |
| Merck Sharp & Dohme LLC | $15.57 | 2021 | |
| Cipher Pharmaceuticals US LLC | $13.74 | 2025 | Spinosad, Natroba |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Geraghty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.